Sigma Planning Corp’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $694K | Sell |
10,053
-1,340
| -12% | -$92.5K | 0.02% | 647 |
|
2025
Q1 | $793K | Sell |
11,393
-362
| -3% | -$25.2K | 0.03% | 563 |
|
2024
Q4 | $1.01M | Sell |
11,755
-3,842
| -25% | -$330K | 0.03% | 482 |
|
2024
Q3 | $1.86M | Sell |
15,597
-967
| -6% | -$115K | 0.06% | 310 |
|
2024
Q2 | $2.36M | Sell |
16,564
-372
| -2% | -$53.1K | 0.07% | 248 |
|
2024
Q1 | $2.17M | Buy |
16,936
+7,299
| +76% | +$937K | 0.07% | 286 |
|
2023
Q4 | $997K | Sell |
9,637
-1,923
| -17% | -$199K | 0.08% | 271 |
|
2023
Q3 | $1.05M | Buy |
11,560
+5,628
| +95% | +$512K | 0.04% | 444 |
|
2023
Q2 | $480K | Buy |
5,932
+1,758
| +42% | +$142K | 0.02% | 747 |
|
2023
Q1 | $332K | Sell |
4,174
-618
| -13% | -$49.2K | 0.01% | 966 |
|
2022
Q4 | $324K | Sell |
4,792
-584
| -11% | -$39.5K | 0.01% | 935 |
|
2022
Q3 | $268K | Sell |
5,376
-376
| -7% | -$18.7K | 0.01% | 980 |
|
2022
Q2 | $321K | Buy |
5,752
+864
| +18% | +$48.2K | 0.01% | 955 |
|
2022
Q1 | $271K | Sell |
4,888
-48
| -1% | -$2.66K | 0.01% | 1096 |
|
2021
Q4 | $276K | Buy |
4,936
+200
| +4% | +$11.2K | 0.01% | 1114 |
|
2021
Q3 | $227K | Buy |
+4,736
| New | +$227K | 0.01% | 1185 |
|
2016
Q1 | – | Sell |
-7,156
| Closed | -$208K | – | 743 |
|
2015
Q4 | $208K | Sell |
7,156
-1,056
| -13% | -$30.7K | 0.03% | 587 |
|
2015
Q3 | $223K | Buy |
+8,212
| New | +$223K | 0.04% | 526 |
|
2015
Q2 | – | Sell |
-16,954
| Closed | -$453K | – | 751 |
|
2015
Q1 | $453K | Buy |
16,954
+100
| +0.6% | +$2.67K | 0.06% | 371 |
|
2014
Q4 | $357K | Buy |
+16,854
| New | +$357K | 0.05% | 440 |
|